1. Home
  2. CELU vs ABLV Comparison

CELU vs ABLV Comparison

Compare CELU & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • ABLV
  • Stock Information
  • Founded
  • CELU 2016
  • ABLV 2015
  • Country
  • CELU United States
  • ABLV China
  • Employees
  • CELU N/A
  • ABLV N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • CELU Health Care
  • ABLV
  • Exchange
  • CELU Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • CELU 56.9M
  • ABLV 51.4M
  • IPO Year
  • CELU N/A
  • ABLV N/A
  • Fundamental
  • Price
  • CELU $2.00
  • ABLV $0.96
  • Analyst Decision
  • CELU Strong Buy
  • ABLV
  • Analyst Count
  • CELU 1
  • ABLV 0
  • Target Price
  • CELU $6.00
  • ABLV N/A
  • AVG Volume (30 Days)
  • CELU 167.1K
  • ABLV 21.1K
  • Earning Date
  • CELU 12-05-2025
  • ABLV 04-23-2025
  • Dividend Yield
  • CELU N/A
  • ABLV N/A
  • EPS Growth
  • CELU N/A
  • ABLV N/A
  • EPS
  • CELU N/A
  • ABLV 0.05
  • Revenue
  • CELU $44,590,000.00
  • ABLV $114,319,869.00
  • Revenue This Year
  • CELU N/A
  • ABLV N/A
  • Revenue Next Year
  • CELU $76.00
  • ABLV N/A
  • P/E Ratio
  • CELU N/A
  • ABLV $20.29
  • Revenue Growth
  • CELU 4.45
  • ABLV N/A
  • 52 Week Low
  • CELU $1.00
  • ABLV $0.55
  • 52 Week High
  • CELU $5.22
  • ABLV $1.77
  • Technical
  • Relative Strength Index (RSI)
  • CELU 42.49
  • ABLV 50.07
  • Support Level
  • CELU $1.94
  • ABLV $0.88
  • Resistance Level
  • CELU $2.06
  • ABLV $1.12
  • Average True Range (ATR)
  • CELU 0.13
  • ABLV 0.08
  • MACD
  • CELU 0.02
  • ABLV -0.00
  • Stochastic Oscillator
  • CELU 16.47
  • ABLV 32.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: